Your browser doesn't support javascript.
loading
COVID-19 vaccination and breakthrough infections in patients with cancer.
Schmidt, A L; Labaki, C; Hsu, C-Y; Bakouny, Z; Balanchivadze, N; Berg, S A; Blau, S; Daher, A; El Zarif, T; Friese, C R; Griffiths, E A; Hawley, J E; Hayes-Lattin, B; Karivedu, V; Latif, T; Mavromatis, B H; McKay, R R; Nagaraj, G; Nguyen, R H; Panagiotou, O A; Portuguese, A J; Puc, M; Santos Dutra, M; Schroeder, B A; Thakkar, A; Wulff-Burchfield, E M; Mishra, S; Farmakiotis, D; Shyr, Yu; Warner, J L; Choueiri, T K.
Afiliação
  • Schmidt AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Hsu CY; Department of Biostatistics, Vanderbilt University, Nashville, USA.
  • Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Balanchivadze N; Hematology and Oncology Fellowship Program, Henry Ford Cancer Institute, Detroit, USA.
  • Berg SA; Department of Internal Medicine and Cancer Biology, Division of Hematology and Oncology, Cardinal Bernardin Cancer Centre, Loyola University Chicago, Maywood, USA.
  • Blau S; Division of Oncology, Northwest Medical Specialties, Tacoma, USA; Division of Hematology, University of Washington, Seattle, USA.
  • Daher A; Hartford HealthCare Medical Group, Hartford, USA.
  • El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Friese CR; University of Michigan School of Nursing, School of Public Health, and Rogel Cancer Centre, Ann Arbor, USA.
  • Griffiths EA; Leukemia Section, Roswell Park Comprehensive Cancer Centre, Buffalo, USA.
  • Hawley JE; Herbert Irving Comprehensive Cancer Centre, Columbia University Irving Medical Centre, New York, USA; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Hayes-Lattin B; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, USA.
  • Karivedu V; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Centre, Columbus, USA.
  • Latif T; Division of Hematology/Medical Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, USA.
  • Mavromatis BH; Department of Cancer, Oncology, Hematology, UPMC Western Maryland, Cumberland, USA.
  • McKay RR; Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, USA.
  • Nagaraj G; Division of Medical Oncology & Hematology, Department of Medicine, Loma Linda University Cancer Centre, Loma Linda, USA.
  • Nguyen RH; Department of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, USA.
  • Panagiotou OA; Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, USA.
  • Portuguese AJ; Division of Hematology, University of Washington, Seattle, USA.
  • Puc M; Department of Surgery, Section of Thoracic Surgery, Virtua Health, Marlton, USA.
  • Santos Dutra M; Segal Cancer Centre of the Jewish General Hospital, Montréal, Canada.
  • Schroeder BA; Virginia Mason Cancer Institute, Seattle, USA.
  • Thakkar A; Division of Oncology, Montefiore Medical Centre, Bronx, USA.
  • Wulff-Burchfield EM; Department of Medicine, Divisions of Medical Oncology and Palliative Medicine, The University of Kansas Health System, Westwood, USA.
  • Mishra S; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USA.
  • Farmakiotis D; Department of Medicine, Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, Providence, USA.
  • Shyr Y; Department of Biostatistics, Vanderbilt University, Nashville, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USA.
  • Warner JL; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USA; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, USA; Department of Biomedical Informatics, Vanderbilt University, Nashville, USA. Electronic address: Jeremy.Warner@vumc.o
  • Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. Electronic address: Toni_Choueiri@dfci.harvard.edu.
Ann Oncol ; 33(3): 340-346, 2022 03.
Article em En | MEDLINE | ID: mdl-34958894

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos